PubMed Central
metadata only
Evaluating adherence in an active-controlled HIV pre-exposure prophylaxis trial (PrEPVacc) to inform the estimation of HIV incidence in a counterfactual placebo arm
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Reconciling counterfactual placebo HIV incidence rate estimates for an active-controlled pre-exposure prophylaxis trial, PrEPVacc#4861
- Complexity of Adherence Challenges: Understanding Syndemic Factors Affecting HIV Treatment Adherence During Treatment Initiation in Cape Town, South Africa.#182471
- PrEP-LANA (Pre-exposure Prophylaxis- Long-acting Novel Antiviral Agent)#804000
- Facilitators and barriers to antiretroviral therapy adherence among adolescents and young adults in rural South Africa#928999
- Increasing PrEP Awareness and Demand Among Black Cisgender Women#1151841
Record · ID 403281
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive